Varian Medical Systems, Inc. (VAR) News

Varian Medical Systems, Inc. (VAR)

Today's Latest Price: $172.86 USD

0.64 (-0.37%)

Updated Sep 18 7:00pm

Add VAR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 138 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

Filter VAR News Items

VAR News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest VAR News From Around the Web

Below are the latest news stories about Varian Medical Systems Inc that investors may wish to consider to help them evaluate VAR as an investment opportunity.

Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Rosetta Stone, Momenta, Jernigan, and Varian on behalf of Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Rosetta Stone Inc. (NYSE: RST), Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), Jernigan Capital, Inc. (NYSE: JCAP), and Varian Medical Systems, Inc. (NYSE: VAR).  Additional information about each potential action can be found at the link provided. Rosetta Stone Inc. (NYSE: RST)Buyer: Cambium Learning GroupOn August 31, 2020, Rosetta Stone announced that it had signed an agreement to be acquired by Cambium for approximately $792 million.  Pursuant to the merger agreement, Rosetta Stone stockholders will receive $30 in cash for each share of Rosetta Stone common stock owned.  The deal is scheduled to close in the fourth quarter ...

Yahoo | September 16, 2020

Lifshitz Law Firm, P.C. Announces Investigation of Immunomedics, Inc. (NASDAQ: IMMU), Livongo Health, Inc. (NASDAQ:LVGO), Varian Medical Systems, Inc. (NYSE: VAR) and Virtusa Corporation (NASDAQ: VRTU)

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU)Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of Immunomedics to Gilead Sciences, Inc. for $88.00 per share in cash. If you are a IMMU investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected] Livongo Health, Inc. (NASDAQ:LVGO)Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of LVGO to Teladoc Health, Inc. for 0.5920x Teladoc shares plus cash consideration of $11.33 per share. If you are a LVGO investor, and would li...

Yahoo | September 16, 2020

SHAREHOLDER ALERT: Monteverde & Associates Reminds Investors of its Ongoing Investigation Regarding the Merger

NEW YORK, NY / ACCESSWIRE / September 16, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * National General Holdings Corp.

Yahoo | September 16, 2020

Varian Expects to Benefit from the Extension of Medical Linear Accelerators Tariff Exclusion in China

Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that the first exclusion of the additional tariffs China imposed on US products will expire on September 16, 2020. In accordance with procedures, the exclusion will be extended by one year, from September 17, 2020 to September 16, 2021. Varian medical linear accelerators are one of the first items to be excluded from additional tariffs.

Yahoo | September 16, 2020

Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), GCI Liberty, Inc. (NASDAQ: GLIBA), Maxim Integrated Products (NASDAQ:MXIM), National General Holdings Corp. (NASDAQ: NGHC), Pfenex Inc. (NYSE: PFNX), Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), and Varian Medical Systems, Inc. (NYSE: VAR)

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)

Yahoo | September 15, 2020

Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1

Highlights:

Yahoo | September 15, 2020

Varian (VAR) Expands Presence With Germany's Ethos Order

Varian's (VAR) Ethos therapy is being adopted in Germany, thus expanding the company's geographic footprint.

Yahoo | September 15, 2020

Varian Announces Appointment of Chris Toth as President and Chief Operating Officer

Varian (NYSE: VAR) today announced the following leadership appointments, effective October 5, 2020:

Yahoo | September 14, 2020

Varian Expands Access to Advanced Cancer Treatment With Ethos

Varian's (VAR) Ethos Therapy used by Goshen Center for Cancer Care marks the expansion access to personalized cancer care.

Yahoo | September 11, 2020

Varian's Halcyon System to Bring Improved Care to Singapore

Varian (VAR) strengthens its partnership Proton Therapy Pte as it brings improved care to Singapore through Halcyon system.

Yahoo | September 8, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5727 seconds.